Your browser doesn't support javascript.
loading
Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study.
Sugimoto, Takeya; Fujimoto, Daichi; Sato, Yuki; Tamiya, Motohiro; Yokoi, Takashi; Tamiya, Akihiro; Iwasawa, Shunichiro; Hata, Akito; Uchida, Junji; Fukuda, Yasushi; Hara, Satoshi; Kanazu, Masaki; Hirano, Katsuya; Kokubo, Masaki; Yamamoto, Nobuyuki.
Afiliación
  • Sugimoto T; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama, Wakayama, Japan.
  • Fujimoto D; Internal Medicine III, Wakayama Medical University, 811-1, Kimiidera, Wakayama, Wakayama, Japan. daichi@wakayama-med.ac.jp.
  • Sato Y; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan. daichi@wakayama-med.ac.jp.
  • Tamiya M; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yokoi T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Tamiya A; Department of Thoracic Oncology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Iwasawa S; Department of Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.
  • Hata A; Department of Respirology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Uchida J; Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
  • Fukuda Y; Department of Respiratory Medicine, Osaka General Medical Center, Osaka, Japan.
  • Hara S; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Kanazu M; Department of Respiratory Medicine, Itami City Hospital, Itami, Japan.
  • Hirano K; Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Japan.
  • Kokubo M; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Yamamoto N; Department of Radiation Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
Invest New Drugs ; 39(3): 853-859, 2021 06.
Article en En | MEDLINE | ID: mdl-33405089
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonitis por Radiación / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Quimioradioterapia / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonitis por Radiación / Carcinoma de Pulmón de Células no Pequeñas / Antígeno B7-H1 / Quimioradioterapia / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2021 Tipo del documento: Article País de afiliación: Japón